V. Werth, “A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris”, J of Skin, vol. 4, no. 1, p. S26, Jan. 2020.